Your browser doesn't support javascript.
loading
Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells.
Gong, Baocheng; Zhang, Jinhua; Hua, Zhongyan; Liu, Zhihui; Thiele, Carol J; Li, Zhijie.
Afiliação
  • Gong B; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
  • Zhang J; Medical Research Center, Liaoning Key Laboratory of Research and Application of Animal Models for Environment and Metabolic Diseases, Shengjing Hospital of China Medical University, Shenyang, China.
  • Hua Z; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
  • Liu Z; Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
  • Thiele CJ; Medical Research Center, Liaoning Key Laboratory of Research and Application of Animal Models for Environment and Metabolic Diseases, Shengjing Hospital of China Medical University, Shenyang, China.
  • Li Z; Cellular and Molecular Biology Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
Front Oncol ; 12: 984514, 2022.
Article em En | MEDLINE | ID: mdl-35992874
[This corrects the article DOI: 10.3389/fonc.2021.686898.].
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça